Why Is Haloette So Hard to Find? [Explained for 2026]

You called your pharmacy. They're out. You tried the one across town — also out of stock. If you've been searching for Haloette, the FDA-approved generic vaginal contraceptive ring, and hitting dead ends, you're not alone. Here's a clear explanation of why this happens and what you can do about it.

What Is Haloette and Why Do People Use It?

Haloette is a branded-generic version of NuvaRing. Like NuvaRing, it contains etonogestrel (a progestin) and ethinyl estradiol (an estrogen) and is inserted into the vagina for three weeks, then removed for one week. It was FDA-approved in 2022 and manufactured by Mayne Pharma in partnership with Mithra. The ring releases 0.12 mg/day of etonogestrel and 0.015 mg/day of ethinyl estradiol — a low, steady dose of hormones that prevents pregnancy by stopping ovulation.

Patients choose Haloette because it's a more affordable alternative to brand-name NuvaRing, and because it offers the convenience of monthly (not daily) dosing. That convenience makes it critical to have it available when you need it — and a stock-out can leave patients scrambling.

Is Haloette in a National Shortage in 2026?

The short answer: No. As of 2026, Haloette is not listed on the FDA Drug Shortages Database or the ASHP shortage list. There is no declared national shortage of etonogestrel/ethinyl estradiol vaginal rings. However, this doesn't mean you won't experience a stock-out at your local pharmacy.

The absence of a declared shortage doesn't mean all pharmacies keep Haloette on their shelves. Local out-of-stock situations are common for a variety of reasons that have nothing to do with a manufacturer crisis.

Why Does Haloette Run Out of Stock at Individual Pharmacies?

Several factors cause individual pharmacies to run low or out of stock on Haloette even when there's no national shortage:

Formulary transitions and generic substitution: Insurance plans change which generic they prefer year to year. When plans switch coverage from brand NuvaRing to Haloette or to another generic, pharmacies adjust their inventory, sometimes leaving gaps.

Low stocking levels at smaller pharmacies: Independent and smaller chain pharmacies often stock fewer specialty items like vaginal rings. If a few patients fill prescriptions in the same week, they can exhaust supply.

Distribution delays: Even without a manufacturer shortage, wholesaler distribution to individual stores can lag, especially in rural areas or regions with less frequent deliveries.

Multiple generics competing for shelf space: There are now three FDA-approved generics of NuvaRing: Haloette, EluRyng, and EnilloRing. Pharmacies may stock only one or two, so if your prescription specifies Haloette, it may be listed as unavailable even though an equivalent ring is in stock.

Why Is It Hard to Know Which Pharmacies Have Haloette in Stock?

One of the most frustrating aspects of finding Haloette is that there's no centralized public database showing real-time pharmacy inventory. GoodRx and other discount services can show you prices but not whether a pharmacy actually has the drug on the shelf right now. That's why patients often end up calling multiple pharmacies — a time-consuming and sometimes fruitless process.

That's where medfinder comes in. medfinder calls pharmacies near you to check which ones can fill your Haloette prescription, so you don't have to make 10 calls yourself. Results are texted directly to you.

What Can You Do Right Now If Haloette Is Unavailable?

If your pharmacy is out of Haloette, you have several options:

Ask about other generics: EluRyng and EnilloRing contain the identical active ingredients as Haloette at the same dose. Ask your pharmacist or provider if they can substitute.

Check larger chain pharmacies: Large-volume pharmacies like CVS, Walgreens, and Walmart tend to maintain more consistent stock than independent pharmacies.

Consider mail-order pharmacy: Mail-order pharmacies often maintain larger stock. A 90-day supply delivered to your door eliminates the monthly pharmacy run entirely.

Talk to your provider about alternatives: If no ring is available nearby, your provider may suggest a temporary switch to a combined oral contraceptive. See our guide to alternatives to Haloette.

How Contraceptive Access Has Improved Since 2019

When NuvaRing was the only vaginal ring option, any supply disruption left patients with far fewer choices. Since 2019, three FDA-approved generic rings have become available — EluRyng, EnilloRing, and Haloette — significantly expanding supply resilience. The introduction of these generics has also driven down cash prices dramatically, from as much as $200 per ring for NuvaRing to as low as $37–$45 with discount coupons for the generics.

This expanded supply means that even if your specific pharmacy is out of Haloette, the chances are good that a nearby pharmacy has EluRyng, EnilloRing, or brand NuvaRing in stock. The challenge is knowing which one — which is exactly the problem medfinder solves.

Key Takeaways

Haloette is NOT in a declared national shortage as of 2026.

Individual pharmacies run low on Haloette due to stocking decisions, formulary transitions, and distribution patterns — not a manufacturer crisis.

EluRyng and EnilloRing are bioequivalent generics that your pharmacy may have in stock even if Haloette isn't available.

There is no centralized real-time pharmacy inventory system — but medfinder can call pharmacies near you to find which ones have it.

For step-by-step tips on locating Haloette at a pharmacy near you, see our guide: How to Find Haloette in Stock Near You.